Patents by Inventor Jignesh Kotecha

Jignesh Kotecha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10772879
    Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof. The formulations of this invention are for treating diseases associated with advanced glycation end products.
    Type: Grant
    Filed: April 5, 2016
    Date of Patent: September 15, 2020
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Chaitanya Dutt, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Ramesh Chandra Gupta, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Manish Patel, Anita Chaudhari
  • Patent number: 10717727
    Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.
    Type: Grant
    Filed: February 4, 2019
    Date of Patent: July 21, 2020
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
  • Patent number: 10471005
    Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.
    Type: Grant
    Filed: February 22, 2017
    Date of Patent: November 12, 2019
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Chaitanya Dutt, Vijay Chauthaiwale, Ram Gupta, Shitalkumar Zambad, Shailesh Deshpande, Jignesh Kotecha, Ramesh Gupta, Sanjay Srivastava, Laxmikant Chhipa, Jaya Abraham
  • Publication number: 20190169175
    Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.
    Type: Application
    Filed: February 4, 2019
    Publication date: June 6, 2019
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
  • Patent number: 10233175
    Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.
    Type: Grant
    Filed: April 5, 2016
    Date of Patent: March 19, 2019
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Chaitanya Dutt, Rameshchandra Gupta, Manish Patel, Jaya Abraham, Vivek Mishra, Amit Kesarwani, Shailesh Deshpande, Shital Kumar Zambad, Anoop Mathur, Jignesh Kotecha, Sachin Latad, Anita Chaudhari
  • Publication number: 20180118728
    Abstract: The present invention relates to novel pyridinium compounds, their isomers, steroisomers, atropisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses process for preparing novel compounds and pharmaceutical composition of said compounds. The invention further relates to the use of the above mentioned compounds for the preparation of medicament for use as pharmaceuticals.
    Type: Application
    Filed: April 5, 2016
    Publication date: May 3, 2018
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Rameshchandra GUPTA, Manish PATEL, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Anita CHAUDHARI
  • Publication number: 20180110763
    Abstract: This invention relates to pharmaceutical formulations comprising 1-(2-thien-2?-yl-2-oxo-ethyl)-3-(methanesulfonyl hydrazine carbonyl) pyridinium, its pharmaceutically acceptable salts, salt-cocrystals and co-crystals, particularly 1-(2-thien-2?-yl-2-oxo-ethyl)-3-5(methanesulfonyl hydrazine carbonyl) pyridinium chloride. The formulations are suitable for oral administration and also comprise a permeability enhancer or a suitable base or a mixture thereof.
    Type: Application
    Filed: April 5, 2016
    Publication date: April 26, 2018
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Jaya ABRAHAM, Vivek MISHRA, Amit KESARWANI, Ramesh Chandra GUPTA, Shailesh DESHPANDE, Shital Kumar ZAMBAD, Anoop MATHUR, Jignesh KOTECHA, Sachin LATAD, Manish PATEL, Anita CHAUDHARI
  • Publication number: 20170157129
    Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.
    Type: Application
    Filed: February 22, 2017
    Publication date: June 8, 2017
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Vijay CHAUTHAIWALE, Ram GUPTA, Shitalkumar ZAMBAD, Shailesh DESHPANDE, Jignesh KOTECHA, Ramesh GUPTA, Sanjay SRIVASTAVA, Laxmikant CHHIPA, Jaya ABRAHAM
  • Patent number: 9610247
    Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.
    Type: Grant
    Filed: May 12, 2014
    Date of Patent: April 4, 2017
    Assignee: Torrent Pharmaceuticals Limited
    Inventors: Chaitanya Dutt, Vijay Chauthaiwale, Ram Gupta, Shitalkumar Zambad, Shailesh Deshpande, Jignesh Kotecha, Ramesh Gupta, Sanjay Srivastava, Laxmikant Chhipa, Jaya Abraham
  • Publication number: 20160120801
    Abstract: Present invention relates to a low dose pharmaceutical composition, preferably oral composition comprising therapeutically effective amount of [(2-hydroxy-4-oxo-6,7,8,9-tetrahydro-4H,5H-10-thia-1,4a-diaza-benzo[a]azulene-3-carbonyl)-amino]-acetic acid (compound A) in the range of 2.5 mg to 60 mg. Present invention also relates to a method of treating inflammatory bowel disease in a mammal by administrating said low dose pharmaceutical composition. Further, present invention relates to a use of the compound A for the preparation of low dose pharmaceutical composition for the treatment of inflammatory bowel disease in a mammal.
    Type: Application
    Filed: May 12, 2014
    Publication date: May 5, 2016
    Applicant: TORRENT PHARMACEUTICALS LIMITED
    Inventors: Chaitanya DUTT, Vijay CHAUTHAIWALE, Ram GUPTA, Shitalkumar ZAMBAD, Shailesh DESHPANDE, Jignesh KOTECHA, Ramesh GUPTA, Sanjay SRIVASTAVA, Laxmikant CHHIPA, Jaya ABRAHAM
  • Publication number: 20120046317
    Abstract: The present invention relates to a new class of heterocyclic compounds and pharmaceutically acceptable salts thereof, process for preparing the same, pharmaceutical composition containing these compounds and to their use in treatment of diseases caused due to formation and accumulation of AGEs (Advanced Glycation end products). The compounds of the present invention are useful for the treatment of diabetic and aging-related complications caused by formation and accumulation of AGEs, such as neuropathy, nephropathy, microangiopathy, retinopathy, hypertension, heart failure, atherosclerosis, Alzheimer's disease & dermatological disorders.
    Type: Application
    Filed: May 6, 2010
    Publication date: February 23, 2012
    Inventors: Chaitanya Dutt, Vijay Chauthaiwale, Ramesh Chandra Gupta, Manish Patel, Jignesh Kotecha, Sachin Latad, Jaya Abraham, Sanjay Srivastava, Milin Rode, Shailesh Deshpande, Anita Chaudhary, Amit Kumar Kesarwani